EUCTR2008-003690-40-IT
Active, not recruiting
Not Applicable
ow-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sitesJuly 30, 2008
Conditionsadvanced and/or metastatic NSCLCMedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastatic
DrugsALIMTA
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- advanced and/or metastatic NSCLC
- Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •histologic or cytologic confirmation of NSCLC
- •measurable disease
- •PS \= ECOG 0\-2
- •WBC ≥3500 e PLT ≥ 100\.000
- •adequate bone marrow, renal, and hepatic function.
- •written informed consent before treatment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
Exclusion Criteria
- •prior chemotherapy with pemetrexed
- •autoimmune disease interfering with radiotherapy
- •other concomitant neoplasm
- •mentally disturbed patients with low compliance to treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with limited metastatic disease - TNT-OES-1 TRIANL-OMON49762Erasmus MC, Universitair Medisch Centrum Rotterdam20
Recruiting
Not Applicable
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with oligometastatic diseaseNL-OMON23939Erasmus MC20
Active, not recruiting
Phase 1
Chemotherapy followed by chemoradiotherapy for metastatic esophageal cancerPatients (18 – 75 years) who are diagnosed with adenocarcinoma of the oesophagus or GOJ with a resectable primary tumour and de-novo synchronous oligometastatic disease.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-003605-55-NLErasmus MC - University Medical Centre20
Unknown
Phase 3
A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial-This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron-RF8radiation therapychemotherapyTCTR20180711002Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy90
Recruiting
Not Applicable
Clinical trial of concurrent chemoradiotherapy (CCRT) with S-1 in patients with advanced head and neck squamous cell carcinoma, who is not eligible for CCRT with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) regimeadvanced head and neck squamous cell carcinomaJPRN-UMIN000021870Yokohama City University hospital40